Decreased expression of IL-17 pathway genes in blood in patients with plaque psoriasis treated with the anti-IL-17A monoclonal antibody, ixekizumab

被引：0
|
作者：
Krueger, J. G. [1 ]
Dow, E. R. [2 ]
Nantz, E. [2 ]
Komocsar, W. J. [2 ]
Banerjee, P. [2 ]
Leonardi, C. [3 ]
Cameron, G. S. [2 ]
Banerjee, S. [2 ]
Hoffman, R. W. [2 ]
机构：
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2013年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
104
引用
收藏
页码：S18 / S18
页数：1
相关论文
共 50 条
  • [21] Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Psoriasis
    Wu, Jashin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 274 - 275
  • [22] HTLV-1 carrier psoriasis patients treated by anti-IL-23/IL-17
    Hamada, Kaoru
    Sawada, Yu
    Hino, Ryosuke
    Nakamura, Motonobu
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (02) : E154 - E154
  • [23] Immunogenicity of the anti-IL-17A antibody secukinumab in healthy subjects and patients
    Klein, U.
    Liang, E.
    Vogel, B.
    Kolbinger, F.
    Bruin, G.
    Lloyd, P.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S172 - S172
  • [24] Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis
    Frieder, Jillian
    Kivelevitch, Dario
    Menter, Alan
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (01) : 5 - 21
  • [25] Erythrodermic Psoriasis Successfully Treated with Anti IL-17: A Case Series
    Bernardini, Nicoletta
    Skroza, Nevena
    Proietti, Ilaria
    Mambrin, Alessandra
    Marchesiello, Anna
    Tolino, Ersilia
    Balduzzi, Veronica
    Potenza, Concetta
    ACTA DERMATOVENEROLOGICA CROATICA, 2021, 29 (04) : 191 - 195
  • [26] Safety profile of ixekizumab, an anti-IL-17 monoclonal antibody, in chronic plaque psoriasis patients after at least 1 year of open label treatment
    Gordon, Kenneth
    Leonardi, Craig
    Braun, Daniel
    Cameron, Gregory
    Erickson, Janelle
    Lebwohl, Mark
    Heffernan, Michael
    Banerjee, Subhashis
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB184 - AB184
  • [27] Transcriptomic analysis of plaque psoriasis during anti-IL-17A biologic therapy and drug withdrawal
    Chen, L.
    Zhang, L.
    Xu, X.
    Xu, Q.
    Xue, F.
    Hao, P.
    Li, X.
    Zheng, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S341 - S341
  • [28] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [29] Onset of Plaque Psoriasis Treatment Responses With Anti IL-17/IL-23 Biologic Therapies
    Fried, Richard G.
    Lebwohl, Mark
    Bettencourt, Miriam
    Koo, John
    Jacobson, Abby
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (08) : 854 - 860
  • [30] Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis
    L. E. Durham
    B. W. Kirkham
    L. S. Taams
    Current Rheumatology Reports, 2015, 17
12345